Extended follow-up of anti-HBe-positive patients with chronic hepatitis B retreated with ribavirin and interferon-α

Antiviral Research

Volumn 52, Issue 2, 2001, Pages 147-152

  Carreño, Vicente ^a   Rico, Miguel A ^a   Pardo, Margarita ^a   Antonio Quiroga, Juan ^a  

^a Fundacion para el Estudio de Las Hepatitis Virales   (Spain)

Author keywords

Chronic hepatitis B virus infection; Interferon therapeutic use; Ribavirin therapeutic use

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; GAMMA INTERFERON; HEPATITIS B(E) ANTIBODY; RIBAVIRIN; VIRUS DNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS B VIRUS; HUMAN; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REDUCTION; RELAPSE; RETREATMENT; TIME; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON TYPE I; MALE; MIDDLE AGED; PILOT PROJECTS; RIBAVIRIN;

HEPATITIS B VIRUS;

EID: 0034775020     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00179-6     Document Type: Article

References (31)

1. Interferon therapy for chronic viral hepatitis: Status report
2. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
3. Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis
4. Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B
5. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection
6. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients
7. A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B
8. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B
9. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection
10. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay
11. Oral ganciclovir treatment in chronic hepatitis B virus infection: A pilot study
12. Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: A randomized study
13. Acute exacerbation of chronic hepatitis B virus infection after withdrawal of lamivudine therapy
14. The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses
15. + T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection
16. Interferon-gamma production specific for hepatitis B virus antigen by intrahepatic T lymphocytes in patients with acute and chronic hepatitis B
17. Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: A viral dynamics study
18. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B
19. + T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants
20. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection
21. Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B
22. Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: Results of a pilot study
23. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon
24. Persistence of viral replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B
25. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon-α
26. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B
27. Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine
28. Histopathological aspects of viral hepatitis
29. Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B lamivudine precore mutant study group
30. Antiviral chemotherapy for the treatment of hepatitis B virus infections
31. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion